戻る Agenda
Session 6: Data Transparency: How do We Measure Up?
Session Chair(s)
Melanie North, PhD
Manager, Clinical Trial Transparency and Disclosure
United States
In this session we will hear from prominent commentators on the status of clinical trial data disclosure in 2017. We will start with a discussion about the reporting of outcome measures and hear the latest on the All Trials TrialsTracker and the Good Pharma Scorecard. As a late-breaking addition we will hear industry’s response and analysis of compliance with clinical trial registration and reporting requirements.
Learning Objective :
Speaker(s)
Speaker
Henry Drysdale
University of Oxford, United Kingdom
Honorary Clinical Research Fellow
Speaker
April Clyburne-Sherin
Sense About Science USA, United States
AllTrials USA Campaign Manager
Speaker
Jennifer Miller, PhD
Yale School of Medicine, United States
Associate Professor of Medicine; Co-Director, Program for Biomedical Ethics
Speaker
Olivia Shopshear, MS
Biogen, United States
Senior Director, US Regulatory Policy Lead
Q&A Panel Discussion
Panel Discussion
All Session Speakers, United States